Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Anthracycline Followed by Docetaxel in Advanced Breast Cancer
NCT00620100Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Sep 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by Sanofi. Started Sep 2004; status: terminated.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00620100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620100.